Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

The role of brain interleukin-1 in stress-enhanced fear learning.

Jones ME, Lebonville CL, Barrus D, Lysle DT.

Neuropsychopharmacology. 2015 Mar 13;40(5):1289-96. doi: 10.1038/npp.2014.317.

PMID:
25430780
2.

Region-specific contribution of the ventral tegmental area to heroin-induced conditioned immunomodulation.

Hutson LW, Szczytkowski JL, Saurer TB, Lebonville C, Fuchs RA, Lysle DT.

Brain Behav Immun. 2014 May;38:118-24. doi: 10.1016/j.bbi.2014.01.008. Epub 2014 Jan 24.

3.

Heroin-induced conditioned immunomodulation requires expression of IL-1β in the dorsal hippocampus.

Szczytkowski JL, Lebonville C, Hutson L, Fuchs RA, Lysle DT.

Brain Behav Immun. 2013 May;30:95-102. doi: 10.1016/j.bbi.2013.01.076. Epub 2013 Jan 26.

4.

Morphine prevents the development of stress-enhanced fear learning.

Szczytkowski-Thomson JL, Lebonville CL, Lysle DT.

Pharmacol Biochem Behav. 2013 Jan;103(3):672-7. doi: 10.1016/j.pbb.2012.10.013. Epub 2012 Nov 13.

PMID:
23159544
5.

Ventral tegmental area-basolateral amygdala-nucleus accumbens shell neurocircuitry controls the expression of heroin-conditioned immunomodulation.

Szczytkowski JL, Fuchs RA, Lysle DT.

J Neuroimmunol. 2011 Aug 15;237(1-2):47-56. doi: 10.1016/j.jneuroim.2011.06.002. Epub 2011 Jul 1.

6.

Dopamine D1 receptors within the basolateral amygdala mediate heroin-induced conditioned immunomodulation.

Szczytkowski JL, Lysle DT.

J Neuroimmunol. 2010 Sep 14;226(1-2):38-47. doi: 10.1016/j.jneuroim.2010.05.029. Epub 2010 Jun 3.

7.

Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations.

Saurer TB, Ijames SG, Lysle DT.

J Pharmacol Exp Ther. 2009 Jun;329(3):1040-7. doi: 10.1124/jpet.108.148627. Epub 2009 Mar 3.

8.

Conditioned effects of heroin on proinflammatory mediators require the basolateral amygdala.

Szczytkowski JL, Lysle DT.

Eur J Neurosci. 2008 Nov;28(9):1867-76. doi: 10.1111/j.1460-9568.2008.06472.x.

9.

Standardization for transcriptomic molecular markers to screen human colon cancer.

Ahmed FE, Vos PW, Ijames S, Lysle DT, Flake G, Sinar DR, Naziri W, Marcuard SP.

Cancer Genomics Proteomics. 2007 Nov-Dec;4(6):419-31.

10.

Transcriptomic molecular markers for screening human colon cancer in stool and tissue.

Ahmed FE, Vos P, iJames S, Lysle DT, Allison RR, Flake G, Sinar DR, Naziri W, Marcuard SP, Pennington R.

Cancer Genomics Proteomics. 2007 Jan-Feb;4(1):1-20.

11.

Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.

Saurer TB, Ijames SG, Carrigan KA, Lysle DT.

Brain Behav Immun. 2008 Jan;22(1):89-97. Epub 2007 Aug 3.

12.

Sex differences in the potency of kappa opioids and mixed-action opioids administered systemically and at the site of inflammation against capsaicin-induced hyperalgesia in rats.

Lomas LM, Barrett AC, Terner JM, Lysle DT, Picker MJ.

Psychopharmacology (Berl). 2007 Apr;191(2):273-85. Epub 2007 Jan 16.

PMID:
17225166
13.

Conditioned effects of heroin on the expression of inducible nitric oxide synthase in the rat are susceptible to extinction and latent inhibition.

Szczytkowski JL, Lysle DT.

Psychopharmacology (Berl). 2007 May;191(4):879-89. Epub 2007 Jan 9.

PMID:
17211650
14.

Neurokinin 1 receptor signaling mediates sex differences in mu and kappa opioid-induced enhancement of contact hypersensitivity.

Elliott JC, Wagner AF, Lysle DT.

J Neuroimmunol. 2006 Dec;181(1-2):100-5. Epub 2006 Oct 4.

PMID:
17023055
15.

Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.

Saurer TB, Ijames SG, Lysle DT.

J Neuroimmunol. 2006 Aug;177(1-2):18-26.

PMID:
16766046
16.

Dissociation between sex differences in the immunological, behavioral, and physiological effects of kappa- and delta-opioids in Fischer rats.

Elliott JC, Picker MJ, Sparrow AJ, Lysle DT.

Psychopharmacology (Berl). 2006 Mar;185(1):66-75. Epub 2006 Jan 6.

PMID:
16397747
17.

Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell.

Saurer TB, Carrigan KA, Ijames SG, Lysle DT.

J Neuroimmunol. 2006 Apr;173(1-2):3-11. Epub 2005 Dec 20.

PMID:
16364456
18.

Improved methods for extracting RNA from exfoliated human colonocytes in stool and RT-PCR analysis.

Ahmed FE, James SI, Lysle DT, Dobbs LJ Jr, Johnke RM, Flake G, Stockton P, Sinar DR, Naziri W, Evans MJ, Kovacs CJ, Allison RR.

Dig Dis Sci. 2004 Nov-Dec;49(11-12):1889-98.

PMID:
15628722
19.

Isolation of circulating colon carcinoma cells for reverse transcriptase polymerase chain reaction.

Ahmed FE, Dobbs LJ Jr, Johnke RM, James S, Lysle DT, Sinar DR, Naziri W, Evans MJ, Kovacs CJ, Daly BM, Allison RR.

Anal Biochem. 2004 Sep 15;332(2):394-7. No abstract available.

PMID:
15325309
20.

Buprenorphine produces naltrexone reversible alterations of immune status.

Carrigan KA, Saurer TB, Ijames SG, Lysle DT.

Int Immunopharmacol. 2004 Mar;4(3):419-28.

PMID:
15037219
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk